Bone Marrow Transplantation - Table of Contents alert Volume 47 Issue 6

TABLE OF CONTENTS Volume 47, Issue 6 (June 2012) In this issue Reviews Special Report Original Articles Letters to the Editor Book Review Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press? Use of Aspirin postdiagnosis improves survival for colon cancer patients E Bastiaannet, K Sampieri et al. Read this Article now!   Reviews Top The EBMT risk score A Gratwohl Bone Marrow Transplant 2012 47: 749-756; advance online publication, June 6, 2011; 10.1038/bmt.2011.110 Abstract | Full Text Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies A M J Braamse, M M J G Gerrits, B van Meijel, O Visser, P van Oppen, A D Boenink, P Cuijpers, P C Huijgens, A T F Beekman and J Dekker Bone Marrow Transplant 2012 47: 757-769; advance online publication, July 4, 2011; 10.1038/bmt.2011.130 Abstract | Full Text Special Report Top Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation J A Snowden, R Saccardi, M Allez, S Ardizzone, R Arnold, R Cervera, C Denton, C Hawkey, M Labopin, G Mancardi, R Martin, J J Moore, J Passweg, C Peters, M Rabusin, M Rovira, J M van Laar and D Farge on behalf of the EBMT Autoimmune Disease Working Party (ADWP) and Paediatric Diseases Working Party (PDWP) Bone Marrow Transplant 2012 47: 770-790; advance online publication, October 17, 2011; 10.1038/bmt.2011.185 Abstract | Full Text Original Articles Top STEM CELL PROCUREMENT Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptors J Clausen, B Kircher, J Auberger, P Schumacher, C Grabmer, A Mühlbacher, G Gastl and D Nachbaur Bone Marrow Transplant 2012 47: 791-798; advance online publication, September 26, 2011; 10.1038/bmt.2011.187 Abstract | Full Text CORD BLOOD STEM CELLS Factors predicting single-unit predominance after double umbilical cord blood transplantation P Ramirez, J E Wagner, T E DeFor, B R Blazar, M R Verneris, J S Miller, D H McKenna, D J Weisdorf, P B McGlave and C G Brunstein Bone Marrow Transplant 2012 47: 799-803; advance online publication, September 26, 2011; 10.1038/bmt.2011.184 Abstract | Full Text ALLOGRAFTING Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy Z Zimmerman, B L Scott, A K Gopal, B M Sandmaier, D G Maloney and H J Deeg Bone Marrow Transplant 2012 47: 804-809; advance online publication, September 12, 2011; 10.1038/bmt.2011.180 Abstract | Full Text Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis H J Khoury, M Kukreja, J M Goldman, T Wang, J Halter, M Arora, V Gupta, D A Rizzieri, B George, A Keating, R P Gale, D I Marks, P L McCarthy, A Woolfrey, J Szer, S A Giralt, R T Maziarz, J Cortes, M M Horowitz and S J Lee Bone Marrow Transplant 2012 47: 810-816; advance online publication, October 10, 2011; 10.1038/bmt.2011.194 Abstract | Full Text POST-TRANSPLANT EVENTS Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors D-F Chen, V K Prasad, G Broadwater, N L Reinsmoen, A DeOliveira, A Clark, K M Sullivan, J P Chute, M E Horwitz, C Gasparetto, G D Long, Y Yang, N J Chao and D A Rizzieri Bone Marrow Transplant 2012 47: 817-823; advance online publication, December 5, 2011; 10.1038/bmt.2011.181 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD F L Dignan, D Greenblatt, M Cox, J Cavenagh, H Oakervee, J F Apperley, A K Fielding, A Pagliuca, G Mufti, K Raj, D I Marks, P Amrolia, A Peniket, P Medd, M N Potter, B E Shaw and J J Scarisbrick Bone Marrow Transplant 2012 47: 824-830; advance online publication, September 19, 2011; 10.1038/bmt.2011.186 Abstract | Full Text Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma O Ringdén, S Shrestha, G T da Silva, M-J Zhang, A Dispenzieri, M Remberger, R Kamble, C O Freytes, R P Gale, J Gibson, V Gupta, L Holmberg, H Lazarus, P McCarthy, K Meehan, H Schouten, G A Milone, S Lonial and P N Hari Bone Marrow Transplant 2012 47: 831-837; advance online publication, September 26, 2011; 10.1038/bmt.2011.192 Abstract | Full Text Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses S Morecki, Y Gelfand, E Yacovlev, O Eizik, Y Shabat, I Sagiv and S Slavin Bone Marrow Transplant 2012 47: 838-845; advance online publication, October 24, 2011; 10.1038/bmt.2011.198 Abstract | Full Text MICROBIAL ISSUES ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients O Marchetti, F Lamoth, M Mikulska, C Viscoli, P Verweij and S Bretagne and the European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups Bone Marrow Transplant 2012 47: 846-854; advance online publication, September 19, 2011; 10.1038/bmt.2011.178 Abstract | Full Text QUALITY OF LIFE Differences in mothers’ and fathers’ health-related quality of life after pediatric SCT: a longitudinal study M Barrera, E Atenafu, J Doyle, D Berlin-Romalis and K Hancock Bone Marrow Transplant 2012 47: 855-859; advance online publication, September 26, 2011; 10.1038/bmt.2011.190 Abstract | Full Text TRANSPLANT TECHNOLOGY Apheresis product identification in the transplant center: development of point-of-care protocols for extended blood typing of stem cell apheresis products C Cummerow, P Schwind, M Spicher, G Spohn, C Geisen, E Seifried and H Bönig Bone Marrow Transplant 2012 47: 860-865; advance online publication, September 19, 2011; 10.1038/bmt.2011.182 Abstract | Full Text Letters to the Editor Top ECIL 3-2009 update guidelines for antifungal management L Castagna, S Bramanti, B Sarina, E Todisco, A Ibatici and A Santoro Bone Marrow Transplant 2012 47: 866; advance online publication, August 8, 2011; 10.1038/bmt.2011.154 Full Text Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience S Vokurka, V Koza, A Jungova, J Navratilova, T Svoboda, P Jindra, K Steinerova and R Vyrutova Bone Marrow Transplant 2012 47: 867-868; advance online publication, August 29, 2011; 10.1038/bmt.2011.173 Full Text Infusion of autologous peripheral blood stem cells in an unrelated donor who developed severe aplastic anemia following stem cell donation H Frangoul, W H Navarro, D L Confer and M Jagasia Bone Marrow Transplant 2012 47: 869; advance online publication, August 29, 2011; 10.1038/bmt.2011.174 Full Text Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib L-M Poon and L P Koh Bone Marrow Transplant 2012 47: 870-871; advance online publication, August 29, 2011; 10.1038/bmt.2011.176 Full Text Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia P Chiusolo, E Metafuni, S Bellesi, S Giammarco, T Za, L Laurenti, F Sorà, G Leone and S Sica Bone Marrow Transplant 2012 47: 872-873; advance online publication, September 19, 2011; 10.1038/bmt.2011.183 Full Text Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients J-C Ianotto, A Tempescul, X Yan, P Delepine, R Le Calloch, E Hardy, J-R Eveillard, N Mugnier, C Berthou and G Guillerm Bone Marrow Transplant 2012 47: 874-876; advance online publication, September 26, 2011; 10.1038/bmt.2011.189 Full Text Successful treatment with tandem consolidation using 90yttrium-ibritumomab tiuxetan (Zevalin) and high-dose therapy with autologous PBSCT in a patient with relapsed mantle cell lymphoma presenting as multiple lymphomatous polyposis E J Han, S-A Yang, H-S Sohn, J I Kim, C-S Kang and S-G Cho Bone Marrow Transplant 2012 47: 877-879; advance online publication, September 26, 2011; 10.1038/bmt.2011.193 Full Text Book Review Top Experimental and applied immunotherapy K Rezvani Bone Marrow Transplant 2012 47: 880; 10.1038/bmt.2012.24 Full Text Advertisement Cellular & Molecular Immunology is proud to present the Special Issue on the Humanized Mouse, which describes how the current humanized mouse models have been used to facilitate the study of human immunology and immune pathogenesis by providing a small animal model for hypothesis testing and mechanistic research. Access the Special Issue today!   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.